LIPELLA PHARMACEUTICALS INC (LIPO:OTCMKTS)
$0.1 -0.0045 (-4.3062%)
Analysed LIPELLA PHARMACEUTICALS INC (LIPO:OTCMKTS) News Sources
Lipella Pharmaceuticals Announces U.S. Patent Issuance for Diagnostic Technology
17-06-2025
yahoo.com
Lipella Pharmaceuticals Announces Delisting from Nasdaq Capital Market
20-06-2025
yahoo.com
Lipella Pharmaceuticals Issues Letter from the CEO to Stockholders Following Nasdaq Delisting
25-06-2025
yahoo.com
Lipella Pharmaceuticals to Present at Zacks SCR Life Sciences Virtual Investor Forum and Report Final Phase 2a Results in Oral Lichen Planus
15-09-2025
yahoo.com
Life Science Virtual Investor Forum Agenda Announced for September 18th
16-09-2025
yahoo.com
Lipella Pharmaceuticals Announces Positive Final Results from Phase 2a Study of LP-10 in Oral Lichen Planus
18-09-2025
yahoo.com
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
18-09-2025
yahoo.com
Delisting of Securities from The Nasdaq Stock Market
24-09-2025
yahoo.com
Lipella Pharmaceuticals Inc. Files Voluntary Petitions for Relief Under Chapter 11
31-03-2026
yahoo.com
What is the current price of LIPELLA PHARMACEUTICALS INC (LIPO:OTCMKTS)?
The current price of LIPELLA PHARMACEUTICALS INC (LIPO:OTCMKTS) is $0.1.
LIPELLA PHARMACEUTICALS INC (LIPO:OTCMKTS) absolute price change since previous trading day?
The absolute price change of LIPELLA PHARMACEUTICALS INC (LIPO:OTCMKTS) since the previous trading day is $-0.0045.
LIPELLA PHARMACEUTICALS INC (LIPO:OTCMKTS) percentage price change since previous trading day?
The percentage price change of LIPELLA PHARMACEUTICALS INC (LIPO:OTCMKTS) since the previous trading day is -4.3062%.
What is the most recent average sentiment score for LIPELLA PHARMACEUTICALS INC (LIPO:OTCMKTS)?
The most recent average sentiment score for LIPELLA PHARMACEUTICALS INC (LIPO:OTCMKTS) is 60 out of 100.
What is the most recent average sentiment for LIPELLA PHARMACEUTICALS INC (LIPO:OTCMKTS)?
The most recent sentiment for LIPELLA PHARMACEUTICALS INC (LIPO:OTCMKTS) is .
SEC-8K** Filing Available For LIPELLA PHARMACEUTICALS INC (LIPO:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.